Publication at Second Faculty of Medicine |
2009
Abstract
A national task force representing clinicians (haematologists, oncologists, microbiologists and intensivists), specialist medical societies and working groups prepared evidence-based guidelines for the treatment of established fungal infections - invasive candidiasis - in adult haematology and ICU patients. These guidelines updated those published in the Czech Republic in 2003/2004.
The quality of the clinical trials was assessed using the evidence criteria of the Infectious Diseases Society of America (IDSA) and the updated EORTC/MSG Consensus Group conclusions were used for definitions of invasive fungal disease.